Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasma cell | 6 studies | 25% ± 12% | |
epithelial cell | 5 studies | 33% ± 14% | |
plasmablast | 4 studies | 40% ± 21% | |
classical monocyte | 3 studies | 21% ± 5% | |
conventional dendritic cell | 3 studies | 30% ± 11% | |
hematopoietic precursor cell | 3 studies | 24% ± 3% | |
non-classical monocyte | 3 studies | 19% ± 2% | |
abnormal cell | 3 studies | 21% ± 4% | |
macrophage | 3 studies | 19% ± 4% | |
dendritic cell | 3 studies | 32% ± 3% | |
intestinal crypt stem cell | 3 studies | 19% ± 3% | |
plasmacytoid dendritic cell | 3 studies | 24% ± 5% |
Insufficient scRNA-seq data for expression of ALG3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1721.06 | 1445 / 1445 | 100% | 105.90 | 183 / 183 |
liver | 100% | 2468.05 | 226 / 226 | 100% | 66.04 | 406 / 406 |
ovary | 100% | 1106.71 | 180 / 180 | 100% | 117.85 | 430 / 430 |
skin | 100% | 2334.38 | 1809 / 1809 | 100% | 81.45 | 472 / 472 |
uterus | 100% | 1425.06 | 170 / 170 | 100% | 75.36 | 459 / 459 |
intestine | 100% | 1769.75 | 966 / 966 | 100% | 80.70 | 526 / 527 |
stomach | 100% | 1469.16 | 359 / 359 | 99% | 83.17 | 284 / 286 |
prostate | 100% | 1769.30 | 245 / 245 | 99% | 50.31 | 498 / 502 |
pancreas | 100% | 1635.14 | 328 / 328 | 99% | 46.18 | 176 / 178 |
thymus | 100% | 1665.75 | 653 / 653 | 99% | 30.10 | 598 / 605 |
lung | 100% | 1609.31 | 576 / 578 | 99% | 88.71 | 1142 / 1155 |
breast | 100% | 1702.03 | 459 / 459 | 98% | 56.15 | 1099 / 1118 |
bladder | 100% | 1923.76 | 21 / 21 | 98% | 74.04 | 495 / 504 |
kidney | 100% | 1335.49 | 89 / 89 | 96% | 32.71 | 869 / 901 |
brain | 96% | 656.37 | 2548 / 2642 | 97% | 26.73 | 681 / 705 |
adrenal gland | 100% | 2502.32 | 258 / 258 | 90% | 28.16 | 206 / 230 |
adipose | 100% | 1700.20 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 51.59 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 44.37 | 29 / 29 |
muscle | 100% | 1445.48 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1766.23 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 77.40 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 38.79 | 1 / 1 |
blood vessel | 100% | 1523.50 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 1017.46 | 834 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 1153.67 | 891 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006487 | Biological process | protein N-linked glycosylation |
GO_0006488 | Biological process | dolichol-linked oligosaccharide biosynthetic process |
GO_0006486 | Biological process | protein glycosylation |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0098553 | Cellular component | lumenal side of endoplasmic reticulum membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0000033 | Molecular function | alpha-1,3-mannosyltransferase activity |
GO_0052925 | Molecular function | dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ALG3 |
Protein name | ALG3 alpha-1,3- mannosyltransferase Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase (EC 2.4.1.258) (Asparagine-linked glycosylation protein 3 homolog) (Dol-P-Man-dependent alpha(1-3)-mannosyltransferase) (Dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase) (Dolichyl-phosphate-mannose--glycolipid alpha-mannosyltransferase) (Not56-like protein) Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase (EC 2.4.1.258) (Dol-P-Man-dependent alpha(1-3)-mannosyltransferase) |
Synonyms | NOT NOT56L |
Description | FUNCTION: Adds the first Dol-P-Man derived mannose in an alpha-1,3 linkage to Man5GlcNAc2-PP-Dol. . FUNCTION: Adds the first Dol-P-Man derived mannose in an alpha-1,3 linkage to Man(5)GlcNAc(2)-PP-Dol. . FUNCTION: Adds the first Dol-P-Man derived mannose in an alpha-1,3 linkage to Man(5)GlcNAc(2)-PP-Dol. . |
Accessions | ENST00000414845.5 Q92685 ENST00000446569.1 ENST00000423996.5 ENST00000397676.8 [Q92685-1] F8WE30 F8WF93 C9J7S5 H7BZZ2 ENST00000411922.5 ENST00000455059.5 H7C0X4 ENST00000445626.6 [Q92685-2] |